We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+15.23%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$110B
AUM Growth
+$18.7B
Cap. Flow
+$7.09B
Cap. Flow %
6.45%
Top 10 Hldgs %
8.73%
Holding
3,883
New
532
Increased
1,751
Reduced
1,105
Closed
465

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$618M
2
VALE icon
Vale
VALE
+$332M
3
CELG
Celgene Corp
CELG
+$309M
4
CME icon
CME Group
CME
+$306M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 16.17%
2 Technology 14.41%
3 Consumer Discretionary 10.61%
4 Financials 10.51%
5 Real Estate 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGAL icon
3076
Galicia Financial Group
GGAL
$7.99B
$314K ﹤0.01%
12,300
-201,783
-94% -$6.32M
KSPN
3077
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$314K ﹤0.01%
37,425
+845
+2% +$9.32K
IWR icon
3078
iShares Russell Mid-Cap ETF
IWR
$56B
$313K ﹤0.01%
5,800
-1,600
-22% -$82.9K
CFG icon
3079
Citizens Financial Group
CFG
$30.3B
$312K ﹤0.01%
9,600
-1,422,800
-99% -$49.3M
FUNC icon
3080
First United
FUNC
$285M
$311K ﹤0.01%
+18,039
New +$307K
MBIO icon
3081
Mustang Bio
MBIO
$4.32M
$311K ﹤0.01%
122
+74
+154% +$210K
GPX
3082
DELISTED
GP Strategies Corp.
GPX
$310K ﹤0.01%
25,494
-17,700
-41% -$258K
PLXP
3083
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$308K ﹤0.01%
58,612
+14,900
+34% +$72.9K
GSAT icon
3084
Globalstar
GSAT
$10.7B
$307K ﹤0.01%
+47,587
New +$405K
DDM icon
3085
ProShares Ultra Dow30
DDM
$542M
$306K ﹤0.01%
+13,200
New +$289K
DSS icon
3086
DSS Inc
DSS
$5.39M
$306K ﹤0.01%
423
+20
+5% +$12.5K
CMTA
3087
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$305K ﹤0.01%
+11,700
New +$219K
BPT
3088
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$303K ﹤0.01%
11,400
-59,900
-84% -$1.51M
IJT icon
3089
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
$303K ﹤0.01%
+3,400
New +$300K
NMR icon
3090
Nomura Holdings
NMR
$28.3B
$303K ﹤0.01%
+84,400
New +$330K
RCKT icon
3091
Rocket Pharmaceuticals
RCKT
$340M
$303K ﹤0.01%
17,301
-18,517
-52% -$292K
WIP icon
3092
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$473M
$303K ﹤0.01%
5,600
-2,700
-33% -$145K
FBRX icon
3093
Forte Biosciences
FBRX
$1.57B
$302K ﹤0.01%
+74
New +$286K
ARCO icon
3094
Arcos Dorados Holdings
ARCO
$1.72B
$301K ﹤0.01%
+43,194
New +$351K
PDSB icon
3095
PDS Biotechnology
PDSB
$38.4M
$299K ﹤0.01%
40,364
+12,103
+43% +$101K
IEP icon
3096
Icahn Enterprises
IEP
$5.24B
$297K ﹤0.01%
4,100
-57,200
-93% -$3.99M
COGT icon
3097
Cogent Biosciences
COGT
$6.65B
$296K ﹤0.01%
16,841
+5,841
+53% +$99.8K
URGN icon
3098
UroGen Pharma
URGN
$1.86B
$296K ﹤0.01%
+8,000
New +$335K
REED
3099
DELISTED
Reeds, Inc. Common Stock
REED
$296K ﹤0.01%
2,046
-820
-29% -$107K
CTSO icon
3100
Cytosorbents Corp
CTSO
$22.7M
$294K ﹤0.01%
38,800
-82,900
-68% -$646K

Similar funds

Renaissance Technologies's Q1 2019 Portfolio in Review

As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.

  • Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
  • Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
  • Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
  • Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
  • Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
  • Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
  • Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.